Rudolf Gilmanshin

Dr. Gilmanshin joined PathoGenetix in June of 1998 as the first employee of the company. He has made substantial contributions to the development of all technology platforms. Dr. Gilmanshin came to PathoGenetix from Albert Einstein College of Medicine, New York, where he studied structural transformations of protein molecules. He brings over 27 years of research experience, including work at Los Alamos National Laboratory, various universities, and the Russian Academy of Sciences where he studied protein folding, molecular films, and dynamics of biomolecular systems

Rudolf Gilmanshin is the Vice President, Advanced Platform Research at Pathogenetix. With a background in Biotechnology, Rudolf Gilmanshin has a rich history of leadership and innovation.Rudolf Gilmanshin studied MS Chemical Physics at Moscow Institute of Physics and Technology. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.